- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- January 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 108 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 466 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 72 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 494 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 66 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 67 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 172 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 67 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 84 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 72 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 276 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 387 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 162 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 71 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 200 Pages
Global
From €5240EUR$5,850USD£4,467GBP

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more